Results 221 to 230 of about 20,357,001 (365)

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec   +6 more
wiley   +1 more source

Lessons learned in seven years of comprehensive integrated care in the Kinzigtal – reasons for the success

open access: yesInternational Journal of Integrated Care, 2014
Elisa Kern   +2 more
doaj   +1 more source

The Role of Ayurveda in Chronic Disease Management: A Review of Clinical Evidence. [PDF]

open access: yesCureus
Karambhe AD   +5 more
europepmc   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio   +8 more
wiley   +1 more source

A roadmap for a patient-centred approach to Pompe disease management. [PDF]

open access: yesJ Neurol
Schoser B   +7 more
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Compartment Model for Controlling Infectious Livestock Disease: Cost-Effective Control Strategies for Johne's Disease In Dairy Herds

open access: yes
Replaced with revised version of paper 06/08/11.animal compartment model, dairy cattle disease, Johne’s disease, livestock disease control, Mycobacterium avium subspecies paratuberculosis, Farm Management, Livestock Production/Industries,
Grohn, Yrjo T.   +5 more
core  

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane   +19 more
wiley   +1 more source

Turning the tide : the role of water management to prevent legionnaires\u2019 disease

open access: yes
May 21 at 1:00pm ETReports of Legionnaires\u2019 disease (LD) cases and outbreaks are increasing in the United States. LD is a serious lung infection caused by breathing in small water droplets containing Legionella bacteria.

core  

Home - About - Disclaimer - Privacy